Acutus Medical, Inc. AFIB
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 88.31% | -27.80% | -23.91% | -320.81% | -106.14% |
| Total Depreciation and Amortization | 17.51% | -70.11% | -78.94% | -83.98% | -87.74% |
| Total Amortization of Deferred Charges | 63.05% | 62.67% | 54.63% | -3.82% | -32.82% |
| Total Other Non-Cash Items | -223.96% | 124.46% | 91.10% | 106.24% | 131.25% |
| Change in Net Operating Assets | -537.66% | -211.73% | -2,419.20% | -166.96% | 157.04% |
| Cash from Operations | 49.84% | 21.47% | 14.52% | 12.07% | 25.77% |
| Capital Expenditure | 48.86% | 130.40% | 113.64% | 89.76% | 94.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 9.84% | -64.23% | -72.23% | -91.61% | -75.71% |
| Other Investing Activities | -91.41% | -45.18% | 159.59% | 128.59% | 7.85% |
| Cash from Investing | -62.17% | -53.16% | -8.92% | -49.48% | -44.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -43.55% | -43.55% | 62.16% | -77.22% |
| Repurchase of Common Stock | -- | -- | 86.52% | 68.47% | 68.47% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.12% | 73.59% | -393.86% | -1.21% | -5.15% |
| Cash from Financing | -8.52% | -44.73% | -620.79% | 79.71% | 78.01% |
| Foreign Exchange rate Adjustments | -89.37% | 832.92% | 586.55% | 347.66% | 537.68% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -136.62% | -1,684.20% | 19.02% | -165.59% | -172.23% |